Treatment Strategies for Organ Fibrosis Based on Regulation of Collagen Metabolism

Connective Tissue

Volumn 35, Issue 4, 2003, Pages 193-200

  Inagaki, Yutaka ^a   Higashi, Kiyoshi ^b   Nemoto, Tomoyuki ^c   Kushida, Miwa ^a   Okazaki, Isao ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUMITOMO CHEMICAL CO LTD   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Collagen; Fibrosis; Matrix metalloproteinase; Smad; TGF

Indexed keywords

ALPHA INTERFERON; COLLAGEN; COLLAGEN TYPE 1; COLLAGENASE 3; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 10; INTERSTITIAL COLLAGENASE; PROTEIN INHIBITOR; RECOMBINANT INTERSTITIAL COLLAGENASE; RECOMBINANT PROTEIN; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR; SMAD PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BONE MARROW TRANSPLANTATION; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; ENZYME INHIBITION; FIBROSIS; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSCRIPTION; LIVER FIBROSIS; LUNG FIBROSIS; MEDIATOR; NONHUMAN; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

EID: 1042302821     PISSN: 0916572X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Diegelmann, R.F., Lindblad, W.J., and Cohen, I.K. (1988) Fibrogenic processes during tissue repair. In: Nimni, M.E. (ed) Collagen. Biochemistry and Biomechanics. vol. 2. CRC Press, Boca Raton, pp. 113-131
2. Ramirez, F. and Di Liberto, M. (1990) Complex and diversified regulatory programs control the expression of vertebrate collagen genes. FASEB J. 4, 1616-1623
3. Roberts, A.B., Heine, V.I., Flanders, K.C., and Sporn, M. B. (1990) Transforming growth factor-β. Major role in regulation of extracellular matrix. Ann. NY Acad. Sci. 580, 225-232
4. Heldin, C.-H., Miyazono, K., ten Dijke, P. (1997) TGF-β signaling from cell membrane to nucleus via Smad proteins. Nature 390, 465-471
5. Inagaki, Y., Nemoto, T., Greenwel, P., and Ramirez, F. (1999) Transcriptional activation of type I collagen gene during hepatic fibrogenesis. Connective Tissue 31, 169-173
6. Inagaki, Y., Nemoto, T., and Nakao, A. (2002) Transcriptional regulation of type I collagen gene expression by transforming growth factor-β/Smad signaling and its antagonistic factors. Connective Tissue 34, 139-146
7. Inagaki, Y., Truter, S., and Ramirez, F. (1994) Transforming growth factor-β stimulates α2 (I) collagen gene expression through a cis-acting element that contains an Sp1 binding site. J. Biol. Chem. 269, 14828-14834
8. Inagaki, Y., Truter, S., Greenwel, P., Rojkind, M., Unoura, M., Kobayashi, K., and Ramirez, F. (1995) Regulation of the α2 (I) collagen gene transcription in fatstoring cells derived from a cirrhotic liver. Hepatology 22, 573-579
9. Greenwel, P., Inagaki, Y., Hu, W., Walsh, M., and Ramirez, F. (1997) Sp1 is required for the early response of α2 (I) collagen to transforming factor-β1. J. Biol. Chem. 272, 19738-19745
10. Nakao, A., Imamura, T., Souchenlnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C.-H., Miyazono, K., and ten Dijke, P. (1997) TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362
11. Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., Christian, J.L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., and ten Dijke, P. (1997) Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. Nature 389, 631-635
12. Chen, S.-J., Yuan, W., Mori, Y., Levenson, A., Trojanowska, M., and Varga, J. (1999) Stimulation of type I collagen transcription in human skin fibroblasts by transforming growth factor-β: involvement of Smad3. J. Invest. Dermatol. 112, 49-57
13. Chen, S.-J., Yuan, W., Lo, S., Trojanowska, M., and Varga, J. (2000) Interaction of Smad3 with a proximal Smad-binding element of the human α2 (I) procollagen gene promoter required for transcriptional activation by TGF-β. J. Cell. Physiol. 183, 381-392
14. Zhang, W., Oul, J., Inagaki, Y., Greenwel, P., and Ramirez, F. (2000) Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of α2 (I)-collagen (COL1A2) transcription. J. Biol. Chem. 275, 39237-39245
15. Inagaki, Y., Nemoto, T., Nakao, A., ten Dijke, P., Kobayashi, K., Takehara, K., and Greenwel, P. (2001) Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2 (I) collagen gene transcription. J. Biol. Chem. 276, 16573-16579
16. Poncelet, A.-C. and Schnaper, H.W. (2001) Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2 (I) collagen expression in human glomerular mesangial cells. J. Biol. Chem. 276, 6983-6992
17. Inagaki, Y., Mamura, M., Kanamaru, Y., Greenwel, P., Nemoto, T., Takehara, K., ten Dijke, P., and Nakao, A. (2001) Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J. Cell. Physiol. 187, 117-123
18. Inagaki, Y., Truter, S., Bou-Gharios, G., Garrett, L.A., de Crombrugghe, B., Nemoto, T., and Greenwel, P. (1998) Activation of proα2 (I) collagen promoter during hepatic fibrogenesis in transgenic mice. Biochem. Biophys. Res. Commun. 250, 606-611
19. Schnabl, B., Kweon, Y.O., Frederick, J.P., Wang, X.-F., Rippe, R.A., and Brenner, D.A. (2001) The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34, 89-100
20. Ghosh, A.K., Yuan, W., Mori, Y., and Varga, J. (2000) Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 19, 3546-3555
21. Feng, X.-H., Lin, X., and Derynck, R. (2000) Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15 (Ink4B) transcription in response to TGF-beta. EMBO J. 19, 5178-5193
22. Okuno, M., Akita, K., Moriwaki, H., Kawada, N., Ikeda, K., Kaneda, K., Suzuki, Y., and Kojima, S. (2001) Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β. Gastroenterology 120, 1784-1800
23. Qi, Z., Atsuchi, N., Ooshima, A., Takeshita, A., and Ueno, H. (1999) Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc. Natl. Acad. Sci. USA 96, 2345-2349
24. Nakamura, T., Sakata, R., Ueno, T., Sata, M., and Ueno, H. (2000) Inhibition of transforming growth factor-β prevents progression of liver fibrosis and enhances hepatocyte regeneration in demethylnitrosamine-treated rats. Hepatology 32, 247-255
25. George, J., Roulot, D., Koteliansky, V.E., and Bissell, D. M. (1999) In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: A potential new therapy for hepatic fibrosis. Proc. Natl. Acad. Sci. USA 96, 12719-12724
26. Ueno, H., Sakamoto, T., Nakamura, T., Qi, Z., Atsuchi, N., Takeshita, A., Shimizu, K., and Ohashi, H. (2000) A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum. Gene Ther. 11, 33-42
27. Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., and Iwamoto, I. (1999) Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest. 104, 5-11
28. Kahari, V.M., Chen, Y.Q., Su, M.W., Ramirez, F., and Uitto, J. (1990) Tumor necrosis factor-α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1. Evidence for two distinct mechanisms of inhibition at the transcriptional and post-transcriptional levels. J. Clin. Invest. 86, 1489-1495
29. Inagaki, Y., Truter, S., Tanaka, S., Di Liberto, M., and Ramirez, F. (1995) Overlapping pathways mediate the opposing actions of tumor necrosis factor-α and transforming growth factor-β on α2 (I) collagen gene transcription. J. Biol. Chem. 270, 3353-3358
30. Greenwel, P., Tanaka, S., Penkov, D., Zhang, W., Olive, M., Moll, J., Vinson, C., Di Liberto, M. and Ramirez, F. (2000) Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins. Mol. Cell. Biol. 20, 912-918
31. Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A.A., Rojkind, M., and Bottinger, E.P. (2000) A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev. 14, 187-197
32. Verrecchia, F., Pessah, M., Atfi, A., and Mauviel, A. (2000) Tumor necrosis factor-α inhibits transforming growth factor-β/Smad signaling in human dermal fibroblasts via. AP-1 activation. J. Biol. Chem. 275, 30226-30231
33. Rockey, D.C., Maher, J.J., Jarnagin, W.R., Gabbiani, G., and Friedman, S.L. (1992) Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatology 16, 776-784
34. Mallat, A., Preaux, A.-M., Blazejewski, S., Rosenbaum, J., Dhumeaux, D., and Mavier, P. (1995) Interferon alpha and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21, 1003-1010
35. Czaja, M.J., Weiner, F.R., Takahashi, S., Giambrone, M.-A., van der Meide, P., Schellekens, H., Biempica, L., and Zern, M.A. (1989) γ-interferon treatment inhibits collagen deposition in murine Schistosomiasis. Hepatology 10, 795-800
36. Baroni, G.S., D'Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A.M., and Benedetti, A. (1996) Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23, 1189-1199
37. Lortat-Jacob, H., Baltzer, F., Desmouliere, A., Peyrol, S., and Grimaud, J.A. (1997) Lobular-but not periovular -inhibition of collagen deposition in the liver of S. mansoni infected mice using interferon-γ. J. Hepatol. 26, 894-903
38. Sakaida, I., Uchida, K., Matsumura, Y., and Okita, K. (1998) Interferon gamma treatment prevents collagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis in vivo. J. Hepatol. 28, 471-479
39. Higashi, K., Kouba, D.J., Song, Y.-J., Uitto, J., and Mauviel, A. (1998) A proximal element within the human α2 (I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-α response element, mediates transcriptional repression by interferon-γ. Matrix Biol. 16, 447-456
40. Higashi, K., Inagaki, Y., Suzuki, N., Mitsui, S., Mauviel, A., Kaneko, H., and Nakatsuka, I. (2003) Y-boxbinding protein YB-1 mediates transcriptional repression of human α2 (I) collagen gene expression by interferon-γ. J. Biol. Chem. 278, 5156-5162
41. Ulloa, L., Doody, J., and Massague, J. (1999) Inhibition of transforming growth factor-β/Smad signalling by the interferon-γ/STAT pathway. Nature 397, 710-713
42. Ghosh, A.K., Yuan, W., Mori, Y., Chen, S.J., and Varga, J. (2001) Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β. Integration at the level of p300/CBP transcriptional coactivators. J. Biol. Chem. 276, 11041-11048
43. Higashi, K., Inagaki, Y., Fujimori, K., Nakao, A., Kaneko, H., and Nakatsuka, I. (2003) Interferon-γ interferes with transforming growth factor-β signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem. (in press)
44. Hiramatsu, N., Hayashi, N., Kasahara, A., Hagiwara, H., Takehara, T., Haruna, Y., and Naito, M. (1995) Improvement of liver fibrosis in chronic hepatitis patients treated with natural interferon alpha. Hepatology 22, 135-142
45. Suou, T., Hosho, K., Kishimoto, Y., Horie, Y., and Kawasaki, H. (1995) Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alpha. Hepatology 22, 426-431
46. Manabe, N., Chevallier, M., Chossegros, P., Causse, X., Guerret, S., Trepo, C., and Grimaudo, J.A. (1993) Interferon-α 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatology 18, 1344-1349
47. Duchatelle, V., Marcellin, P., Giostra, E., Bregeaud, L., Pouteau, M., Boyer, N., and Auperin, A. (1998) Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. J. Hepatol. 29, 20-28
48. Sobesky, R., Mathurin, P., Charlotte, F., Moussalli, J., Olivi, M., Vidaud, M., Ratziu, V., Opolon, P., and Poynard, T. (1999) Modeling the impact of interferon alpha treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 116, 378-386
49. Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kiso, S., Doi, Y., Yamada, A., Oshikawa, O., and Matsuzawa, Y. (1999) Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosis. J. Hepatol. 30, 1-7
50. Inagaki, Y., Nemoto, T., Kushida, M., Sheng, Y., Higashi, K., Ikeda K., Kawada, N., Shirasaki, F., Takehara, K., Sugiyama, K., Fujii, M., Yamauchi, H., Nakao, A., de Crombrugghe, B., Watanabe, T., and Okazaki, I. (2003) Interferon a down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology (in press)
51. Nelson, D.R., Lauwers, G.Y., Lau, J.Y.N., and Davis, G. L. (2000) Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118, 655-660
52. Friedman, S.L. and Arthur, M.J.P. (2002) Reversing hepatic fibrosis. Science & Medicine July/August, 194-205
53. Iimuro, Y., Nishio, T., Morimoto, T., Nitta, T., Stefanovic, B., Choi, S.K., and Yamaoka, Y. (2003) Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 124, 445-458
54. Murawaki, Y., Ikuta, Y., Idobe, Y., Kitamura, Y., and Kawasaki, H. (1997) Tissue inhibitor of metalloproteinese-1 in the liver of patients with chronic liver disease. J. Hepatol. 26, 1213-1219
55. Yoshiji, H., Kuriyama, S., Miyamoto, Y., Thorgeirsson, U.P., Gomez, D.E., Kawata, M., Yoshiji, J., Ikenaka, Y., Noguchi, R., Tsujinoue, H., Nakatani, T., Thorgeirsson, S.S., and Fukui, H. (2000) Tissue inhibitor of metalloproteineses-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32, 1248-1254
56. Matsuda, Y., Matsumoto, K., Ichida, T., and Nakamura, T. (1995) J. Biochem. 118, 643-649
57. Yasuda, H., Imai, E., Shiota, A., Fujise, N., Morinaga, T., and Higashio, K. (1996) Antifibrotic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24, 636-642
58. Mizuno, S., Kurosaw, T., Matsumoto, K., Mizuno-Horikawa, Y., Okamoto, M., and Nakamura, T. (1998) Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101, 1827-1834
59. Liu, Y., Rajur, K., Tolbert, E., and Dworkin, L.D. (2000) Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney International 58, 2028-2043
60. Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Takahashi, H., Okamoto, E., and Fujimoto, J. (1999) Nature Med. 5, 226-230
61. Ozaki, I., Zhao, G., Mizuta, T., Ogawa, Y., Hara, T., Kajihara, S., Hisatomi, A., Sakai, T., and Yamamoto, K. (2002) Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via. the transcription factor Ets-1 in human hepatic stellate cells. J. Hepatol. 36, 169-178
62. Watanabe, T., Niioka, M., Hozawa, S., Kameyama, K., Hayashi, T., Arai, M., Ishikawa, A., Maruyama, K., and Okazaki, I. (2000) Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J. Hepatol 33, 224-235
63. Watanabe, T., Niioka, M., Hozawa, S., Sugioka, Y., Arai, M., Maruyama, K., Okano, H., and Okazaki, I. (2003) Stem cells expressing matrix metalloproteinase-13 mRNA appear during regression reversal of hepatic cirrhosis. In: Okazaki, I., Ninomiya, Y., Friedman, S.L., and Tanikawa, K. (eds) Extracellular Matrix and The Liver-Approach to Gene Therapy. Academic Press, New York, pp. 361-388